Solem leverages a series of proprietary tools tailored for life sciences companies, enabling them to map out a clear path towards realising the full value of their assets under development. Each tool aligns with the evolution of a company as they progress through clinical development planning, prelaunch and commercial phases. Our European Navigator provides you with a clear understanding of the paths to market available, with the end goal of building a coherent and executable plan that benefits from our local market expertise, capturing the full potential of the technology to deliver on the commercial promise over the life of the asset. At the intersection of an executable strategy and operational know-how, Navigator maximises your outcome.